Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4377 - 4384 of 11613 results
UPDATE: Court Extends EEO-1 Component 2 Collection Deadline
November 4, 2019| Blog| Viewpoint
Federal Circuit Holds Appointment of PTAB Judges Violates the Constitution, Vacates and Remands Final Written Decision
November 4, 2019| Blog| Viewpoint
Who’s the Boss? She is.
November 4, 2019| News
Second Circuit Affirms the Extraterritorial Discovery Reach of 28 U.S.C. § 1782
November 4, 2019| Blog| Viewpoint
USCIS Announces Premium Processing Fee Increase
November 1, 2019| Alert| Viewpoint
TPS Documentation Extended for Six Countries
November 1, 2019| Alert| Viewpoint
Pro Bono Attorney Spotlight
October 31, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.